Yousefnia Saghar, Ghaedi Kamran, Seyed Forootan Farzad, Nasr Esfahani Mohammad Hossein
1 Division of Cellular and Molecular Biology, Department of Biology, Faculty of Sciences, University of Isfahan, Isfahan, Iran.
2 Department of Cellular Biotechnology, Cell Science Research Center, Royan Institute for Biotechnology, Academic Center for Education, Culture and Research, Isfahan, Iran.
Tumour Biol. 2019 Aug;41(8):1010428319869101. doi: 10.1177/1010428319869101.
Stemness phenotype mammospheres established from cell lines and tissues taken from autopsy can be used to test and to identify the most sensitive drugs for chemotherapy. Therefore, the aim of the present study was isolation and characterization of cancer stem cells derived from MCF7, MDA-MB231, and SKBR3 breast cancer cell lines to demonstrate the stemness phenotypes of mammospheres generated for further their applications in therapeutic approaches. In this study, two luminal subtypes of cell lines, MCF7 and SKBR3 and a basal subtype cell line, MDA-MB-231, were chosen. Mammosphere culturing was implemented for breast cancer stem cells isolation and mammosphere formation efficiency. At the next step, CD44+/CD24- cell ratio, and mRNA levels, proliferation rate, migration rate of mammospheres, and drug resistance (in third passage) were evaluated. In addition, tumorigenicity of mammospheres in the chick embryo model was evaluated and compared through the chick chorioallantoic membrane assay. Among mammospheres formed in all three cell lines, MCF7 had the highest mammosphere formation efficiency. CD24 marker (a differentiation marker for the breast cancer cells) was significantly reduced in the mammospheres generated from MCF7 and SKBR3, during three passages. Also, and transcript levels were significantly higher in all three types of mammospheres, as compared with their cell lines. Proliferation, migration rate, and drug resistance of mammospheres generated from all three cell lines were found to be significantly higher. Tumorigenicity of MCF7 mammospheres was confirmed through tumor size measurement. Also, tumorigenicity of MCF7 and SKBR3 mammospheres was confirmed through more migration from ectoderm to mesoderm and endoderm. We succeeded to establish the technology that can be extended to tissue in the future. We have demonstrated a number of mammospheres can be generated from cell lines. Also, cells with different molecular features showed different stemness phenotypes.
从尸检获取的细胞系和组织中建立的干性表型乳腺球可用于测试和鉴定对化疗最敏感的药物。因此,本研究的目的是分离和鉴定源自MCF7、MDA-MB231和SKBR3乳腺癌细胞系的癌症干细胞,以证明所生成乳腺球的干性表型,以便进一步将其应用于治疗方法中。在本研究中,选择了两种管腔亚型细胞系MCF7和SKBR3以及一种基底亚型细胞系MDA-MB-231。采用乳腺球培养法分离乳腺癌干细胞并评估乳腺球形成效率。下一步,评估CD44+/CD24-细胞比例、mRNA水平、乳腺球的增殖率、迁移率和耐药性(第三代)。此外,通过鸡胚绒毛尿囊膜试验评估并比较了乳腺球在鸡胚模型中的致瘤性。在所有三种细胞系形成的乳腺球中,MCF7的乳腺球形成效率最高。在三代培养过程中,MCF7和SKBR3生成的乳腺球中CD24标记物(乳腺癌细胞的分化标记物)显著降低。此外,与它们的细胞系相比,所有三种类型乳腺球中的 和 转录水平均显著更高。发现所有三种细胞系生成的乳腺球的增殖、迁移率和耐药性均显著更高。通过测量肿瘤大小证实了MCF7乳腺球的致瘤性。此外,通过从外胚层到中胚层和内胚层的更多迁移证实了MCF7和SKBR3乳腺球的致瘤性。我们成功建立了一项未来可扩展到组织的技术。我们已经证明可以从细胞系中生成许多乳腺球。此外,具有不同分子特征的细胞表现出不同的干性表型。